trending Market Intelligence /marketintelligence/en/news-insights/trending/sktrxpzaps4foc45hzyflg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Albertsons' Rite Aid deal clears antitrust hurdle

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

2018 US Property Casualty Insurance Market Report


Albertsons' Rite Aid deal clears antitrust hurdle

Albertsons Cos. Inc. appears to be one step closer to closing its purchase of Rite Aid Corp.

The retail pharmacy chain said in a March 29 statement that federal antitrust regulators had run out of time to request more information about the companies' proposed deal as of 11:59 p.m. on March 28, signaling that the U.S. government will allow the transaction to proceed.

The deal, which would form a single company worth about $24 billion, must now win approval from Rite Aid shareholders, the retailer said. Rite Aid and Albertsons announced the deal in February.

Under the Hart-Scott-Rodino Act, federal antitrust regulators, including the Federal Trade Commission and the U.S. Department of Justice, must request additional information about a deal within certain time frames. If the regulators do not make any requests before the period ends, the deal may proceed.

The Justice Department made such a request of CVS Health Corp. and Aetna Inc. in February. Federal regulators have yet to sign off on that transaction, worth about $69 billion.

Shareholders at both CVS and Aetna voted to approve the deal in mid-March.